BeOne Medicines (BEIGF) Cash from Operations (2015 - 2026)
BeOne Medicines (BEIGF) reported Cash from Operations of 201336000.0 for Q1 2026, up 356.73% year-over-year from 44082000.0 in Q1 2025, and down 51.76% quarter-over-quarter from 417347000.0 in Q4 2025.
BeOne Medicines (BEIGF) Cash from Operations (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of Cash from Operations data on file, last reported at 201336000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 201336000.0, up 356.73% year-over-year; the trailing twelve-month figure through Mar 2026 was 1284834000.0 (up 505.99% YoY), and the FY2025 annual result was 1127580000.0, up 901.8% from the prior year.
- Cash from Operations declined to 201336000.0 in Q1 2026 per BEIGF's latest filing, from 417347000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 417347000.0 in Q4 2025 and troughed at 563777000.0 in Q1 2023.
- A 5-year average of 86222764.71 and a median of 95588000.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 350.36% in 2022, then soared 455.28% in 2025.
- A 5-year view of Cash from Operations shows it stood at 318191000.0 in 2022, then surged by 30.34% to 221638000.0 in 2023, then surged by 133.91% to 75160000.0 in 2024, then soared by 455.28% to 417347000.0 in 2025, then plunged by 51.76% to 201336000.0 in 2026.
- Business Quant data shows BEIGF's Cash from Operations at 201336000.0 in Q1 2026, 417347000.0 in Q4 2025, and 402553000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 201.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.34 Mn |
| Mar 31, 2026 | 201.34 Mn |
| Dec 31, 2025 | 417.35 Mn |
| Dec 31, 2025 | 417.35 Mn |
| Sep 30, 2025 | 402.55 Mn |
| Sep 30, 2025 | 402.55 Mn |
| Jun 30, 2025 | 263.60 Mn |
| Jun 30, 2025 | 263.60 Mn |
| Mar 31, 2025 | 44.08 Mn |
| Mar 31, 2025 | 44.08 Mn |
| Dec 31, 2024 | 75.16 Mn |
| Dec 31, 2024 | 75.16 Mn |
| Sep 30, 2024 | 188.37 Mn |
| Sep 30, 2024 | 188.37 Mn |
| Jun 30, 2024 | -95.59 Mn |
| Jun 30, 2024 | -95.59 Mn |
| Mar 31, 2024 | -308.57 Mn |
| Mar 31, 2024 | -308.57 Mn |
| Dec 31, 2023 | -221.64 Mn |
| Dec 31, 2023 | -221.64 Mn |